Individualized thoracic aortic replacement for the aortopathy of biscuspid aortic valve disease.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3688638)

Published in J Heart Valve Dis on July 01, 2011

Authors

Brian Lima1, Judson B Williams, S Dave Bhattacharya, Asad A Shah, Nicholas Andersen, Andrew Wang, J Kevin Harrison, G Chad Hughes

Author Affiliations

1: Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Articles cited by this

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation (2008) 5.82

Outcomes in adults with bicuspid aortic valves. JAMA (2008) 2.94

A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg (2007) 2.83

Surgery of the thoracic aorta. N Engl J Med (1997) 2.34

Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2007) 2.31

Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg (2007) 2.23

The aortopathy of bicuspid aortic valve disease has distinctive patterns and usually involves the transverse aortic arch. J Thorac Cardiovasc Surg (2008) 2.20

Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation (2009) 2.19

Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc (1999) 1.76

Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76

Technical advances in total aortic arch replacement. Ann Thorac Surg (2004) 1.75

Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg (2004) 1.75

Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation (2000) 1.72

Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71

Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation (2003) 1.69

Is reduction aortoplasty (with or without external wrap) an acceptable alternative to replacement of the dilated ascending aorta? Interact Cardiovasc Thorac Surg (2009) 1.60

Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation (2008) 1.53

Surgery for aneurysms of the aortic root: a 30-year experience. Circulation (2004) 1.45

Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression. Eur J Cardiothorac Surg (2007) 1.40

Improving results of open arch replacement. Ann Thorac Surg (2008) 1.39

Repair of regurgitant bicuspid aortic valves: a systematic approach. J Thorac Cardiovasc Surg (2010) 1.23

Bicuspid aortic valve associated with aortic dilatation: a community-based study. Arterioscler Thromb Vasc Biol (2003) 1.22

Is aortic wall degeneration related to bicuspid aortic valve anatomy in patients with valvular disease? J Thorac Cardiovasc Surg (2008) 1.20

Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg (2003) 1.12

Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther (2008) 1.11

Retrospective study to identify predictors of the presence and rapid progression of aortic dilatation in patients with bicuspid aortic valves. Nat Clin Pract Cardiovasc Med (2008) 1.08

Long-term survival after the Bentall procedure in 206 patients with bicuspid aortic valve. Ann Thorac Surg (2007) 1.08

Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann Thorac Surg (2009) 1.06

Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve. Am J Cardiol (2003) 1.05

Aortic size in acute type A dissection: implications for preventive ascending aortic replacement. Eur J Cardiothorac Surg (2009) 1.01

Bicuspid aortic valves and dilated aortas: a critical review of the ACC/AHA practice guidelines recommendations. Am J Cardiol (2008) 0.90

Anatomic three-dimensional echocardiographic correlation of bicuspid aortic valve. J Am Soc Echocardiogr (2003) 0.87

Feasibility of valve repair for regurgitant bicuspid aortic valves--an echocardiographic study. Ann Thorac Surg (2005) 0.87

Risk factors associated with reoperation and mortality in 252 patients after aortic valve replacement for congenitally bicuspid aortic valve disease. Ann Thorac Surg (2007) 0.84

Articles by these authors

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80

In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med (2013) 3.72

A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A (2006) 3.70

Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis (2012) 3.49

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA (2012) 3.01

Early predictors of in-hospital death in infective endocarditis. Circulation (2004) 2.26

Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. Am Heart J (2004) 2.13

Pure annular dilation as a cause of mitral regurgitation: a clinically distinct entity of female heart disease. J Heart Valve Dis (2009) 2.06

The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06

Cardiac catheterization within 1 to 3 days of proximal aortic surgery is not associated with increased postoperative acute kidney injury. J Thorac Cardiovasc Surg (2012) 2.04

Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation (2010) 2.01

Tracheal ultrasound to assess endotracheal tube depth: an exploratory study. Can J Anaesth (2015) 2.00

Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv (2010) 1.91

Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol (2013) 1.86

Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol (2008) 1.84

Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg (2011) 1.80

Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis (2007) 1.78

Staged total abdominal debranching and thoracic endovascular aortic repair for thoracoabdominal aneurysm. J Vasc Surg (2012) 1.74

Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol (2011) 1.72

The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68

Clinical problem-solving. A hole in the argument. N Engl J Med (2005) 1.62

4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol (2013) 1.62

A previously unreported complication of apicoaortic conduit for severe aortic stenosis. Ann Thorac Surg (2009) 1.57

Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg (2013) 1.54

Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg (2012) 1.54

Contemporary results for proximal aortic replacement in North America. J Am Coll Cardiol (2012) 1.51

Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur J Immunol (2008) 1.45

An anomalous left coronary artery originating from the pulmonary artery in a 72-year-old woman: diagnosis by color flow myocardial blush and coronary arteriography. J Invasive Cardiol (2002) 1.44

Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials (2009) 1.42

Results with an algorithmic approach to hybrid repair of the aortic arch. J Vasc Surg (2012) 1.42

Trained and supervised physician assistants can safely perform diagnostic cardiac catheterization with coronary angiography. Catheter Cardiovasc Interv (2003) 1.39

Ascending-descending aortic bypass with valve-sparing root replacement for coarctation with aortic root aneurysm. J Thorac Cardiovasc Surg (2011) 1.37

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA (2003) 1.36

Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. Am J Cardiol (2005) 1.36

Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res (2005) 1.33

Left main coronary artery-to-pulmonary artery fistula with severe aneurysmal dilatation. Ann Thorac Surg (2004) 1.28

Midterm results for endovascular repair of complicated acute and chronic type B aortic dissection. Ann Thorac Surg (2010) 1.24

Midterm results with thoracic endovascular aortic repair for chronic type B aortic dissection with associated aneurysm. J Thorac Cardiovasc Surg (2011) 1.22

Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair. J Vasc Surg (2012) 1.22

Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J (2012) 1.22

Neurophysiologic intraoperative monitoring during endovascular stent graft repair of the descending thoracic aorta. J Clin Neurophysiol (2007) 1.20

A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. Ann Cardiothorac Surg (2013) 1.19

Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med (2005) 1.18

Successful percutaneous coronary intervention with stent implantation in anomalous right coronary arteries arising from the left sinus of valsalva: a report of two cases. Catheter Cardiovasc Interv (2002) 1.15

Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials (2011) 1.14

Results of proximal arch replacement using deep hypothermia for circulatory arrest: is moderate hypothermia really justifiable? Am Surg (2011) 1.13

Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg (2013) 1.13

HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm (2011) 1.11

Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J (2005) 1.11

HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol (2004) 1.09

Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg (2010) 1.09

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 1.08

Direct en face imaging of secundum atrial septal defects by velocity-encoded cardiovascular magnetic resonance in patients evaluated for possible transcatheter closure. Circ Cardiovasc Imaging (2008) 1.08

Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. J Thromb Thrombolysis (2011) 1.08

Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. Ann Thorac Surg (2012) 1.08

Two-stage total aortic replacement for Loeys-Dietz syndrome. J Card Surg (2010) 1.07

Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J Am Chem Soc (2014) 1.06

Does negative pressure wound therapy have a role in preventing poststernotomy wound complications? Surg Innov (2009) 1.06

Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation (2012) 1.05

Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. Arthritis Rheum (2010) 1.05

Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol (2009) 1.04

Results with a selective revascularization strategy for left subclavian artery coverage during thoracic endovascular aortic repair. Ann Thorac Surg (2011) 1.03

Endovascular repair of descending thoracic aneurysms: results with "on-label" application in the post Food and Drug Administration approval era. Ann Thorac Surg (2010) 1.02

Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum (2002) 1.02

Total aortic replacement in Loeys-Dietz syndrome. J Card Surg (2011) 1.00

Utility of remote wireless pressure sensing for endovascular leak detection after endovascular thoracic aneurysm repair. Ann Thorac Surg (2010) 1.00

Risk factors for 1-year mortality after thoracic endovascular aortic repair. J Thorac Cardiovasc Surg (2012) 0.99

Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage (2011) 0.98

Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. Blood (2008) 0.98

Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA (2011) 0.97

Richard E. Clark Award. Aortic dissection as a complication of cardiac surgery: report from the Society of Thoracic Surgeons database. Ann Thorac Surg (2010) 0.97

Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention (2009) 0.96

Does protected research time during general surgery training contribute to graduates' career choice? Am Surg (2011) 0.96

Elastic energy of protein-DNA chimeras. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.96

Results of thoracic endovascular aortic repair 6 years after United States Food and Drug Administration approval. Ann Thorac Surg (2012) 0.93

Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients. J Am Acad Dermatol (2006) 0.93

Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med (2006) 0.93